Rare Diseases: Drugs

Department of Health and Social Care written question – answered on 14th November 2018.

Alert me about debates like this

Photo of James Frith James Frith Labour, Bury North

To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

Officials have had no such discussions. Health is a devolved matter and the availability of medicines for the treatment of rare diseases in Scotland is an issue for the Scottish Government.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.